Joe Torres
Psychiatric/Mental Health · Bakersfield, CANPI 1831440809
Payments from drug & device makers
Across 346 payments — averaging $29.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Bayer$802
- Corcept Therapeutics$774
- AstraZeneca$744
- GSK$609
- plus $5K from 39 others
What the payments were for
- Food & beverage$10,237100%
- Education$330%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,271 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 125 | $104,372 |
| JardianceEmpagliflozin | 104 | $94,079 |
| OzempicSemaglutide | 55 | $53,509 |
| TradjentaLinagliptin | 33 | $30,329 |
| JanuviaSitagliptin Phosphate | 41 | $26,521 |
| EliquisApixaban | 28 | $23,973 |
| XareltoRivaroxaban | 30 | $22,126 |
| LinzessLinaclotide | 31 | $20,903 |
| MounjaroTirzepatide | 13 | $12,814 |
| EntrestoSacubitril/Valsartan | 12 | $6,178 |
| DapagliflozinDapagliflozin Propanediol | 12 | $6,133 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $5,786 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 61 | $5,601 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $4,885 |
| Tamsulosin Hcl | 142 | $3,781 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $356 | $124,408137 claims |
| AstraZenecaFarxiga | $744 | $104,372125 claims |
| Novo NordiskOzempic | $1,189 | $53,50955 claims |
| MerckJanuvia | $329 | $26,52141 claims |
| PfizerEliquis | $103 | $23,97328 claims |
| Johnson & JohnsonXarelto | $45 | $22,12630 claims |
| AbbVieLinzess | $1,475 | $20,90331 claims |
| Lilly USA, LLCMounjaro | $521 | $12,81413 claims |
| NovartisEntresto | $43 | $6,17812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Bakersfield
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.